Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Gattermann

Blood

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood|October 15, 2016
Iron rusting in the mitochondria?Norbert Gattermann
Blood|October 23, 2012
SF3B1 and the riddle of the ring sideroblastNorbert Gattermann
Blood|July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemiaUlrich Germing, Corinna Strupp, Manuel Aivado, et al.
Blood|October 25, 2003
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndromeNorbert Gattermann, Michael Wulfert, Bärbel Junge, et al.
Blood|January 25, 2007
High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiableNorbert Gattermann, Johan Billiet, Ralf Kronenwett, et al.
Blood|May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acidAndrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
Blood|March 6, 2002
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cellsUlrich Steidl, Ralf Kronenwett, Ulrich-Peter Rohr, et al.
Blood|July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromesAzim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Blood|August 10, 2010
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic valueAlexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood|October 15, 2016
Iron rusting in the mitochondria?Norbert Gattermann
Blood|October 23, 2012
SF3B1 and the riddle of the ring sideroblastNorbert Gattermann
Blood|July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemiaUlrich Germing, Corinna Strupp, Manuel Aivado, et al.
Blood|October 25, 2003
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndromeNorbert Gattermann, Michael Wulfert, Bärbel Junge, et al.
Blood|January 25, 2007
High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiableNorbert Gattermann, Johan Billiet, Ralf Kronenwett, et al.
Blood|May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acidAndrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
Blood|March 6, 2002
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cellsUlrich Steidl, Ralf Kronenwett, Ulrich-Peter Rohr, et al.
Blood|July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromesAzim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Blood|August 10, 2010
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic valueAlexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, et al.
Pageof 2